Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2003
10/08/2003CN1447919A Use of antibodies against specific MHC-Peptide complexes
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447695A Potent immunostimulants from microalgae
10/08/2003CN1446580A Preparation of effective component from rhodiola crenulate
10/08/2003CN1446543A Sea cucumber polysaccharide preparation
10/08/2003CN1123577C Ocean thalassiomycete hypoxylon polyose and its extracting process and application
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/08/2003CN1123358C Oral liquid for treating cerebrovascular disease
10/08/2003CN1123342C Use of inhibitors of renin-angiotension system
10/08/2003CA2424683A1 Hla matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/07/2003US6630588 Dye labeled imidazoquinoline compounds
10/07/2003US6630579 Complex
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630484 6-and 7-substituted analogs of swainsonine their preparation and therapeutic use
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630161 Stable oil in water emulsion; vaccine; squalene, PLURONIC, egg phosphatidyl choline, glycerol, alpha tocopherol
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2258146C Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080841A1 Calcineurin activators
10/02/2003WO2003080837A1 Production of recombinant che a 1 allergen from chenopodium album and system of isolating and purifying same
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080817A1 Process for producing cytotoxic lymphocyte
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080658A1 Novel allergen
10/02/2003WO2003080633A1 Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080619A1 Fused bicyclic pyrimidine derivatives
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080609A1 Pyrazolopyrimidines derivatives
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080114A2 Imidazoquinoline adjuvants for vaccines
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080096A1 Compositions for treating and/or preventing pollenosis
10/02/2003WO2003080087A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080067A1 3-0-'alfa-l-rhamnopyranosyl- (1-2) -alpha-l-rhamnopyranosyl- (1-4) -3beta-d-glucopyranosyl!-25 (s) -spirost an-3beta-ol, process for its isolation, and its use as immunomodulator
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003080038A1 Preventive or therapeutic agent for kidney disease
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003061629A3 Dna dosage forms
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003020767A3 Antibodies against caspase-8, their preparation and use
10/02/2003WO2003013593A3 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002018404A9 Nucleoside derivatives for the treatment of hepatitis c
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187261 Purine derivatives, process for their preparation and use thereof
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187221 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187016 Viricides; anticancer agents
10/02/2003US20030187014 Condensed pyrazole derivatives, process for producing the same and use thereof
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186988 Lymphocyte disease; autoimmune disease
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
1 ... 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 ... 1172